TrialCancer chemotherapy and pharmacology2022

Evaluation of drug-drug interactions between midostaurin and strong CYP3A4 inhibitors in patients with FLT-3-mutated acute myeloid leukemia (AML).

Romain Sechaud et al.PubMed ↗Publisher ↗

No numbers read from the abstract.